IZG
3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione
Find entries where: IZG
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione |
Identifiers | 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodo-phenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidine-4,7-dione |
Formula | C17 H15 F2 I N4 O4 |
Molecular Weight | 504.227 |
Type | NON-POLYMER |
Isomeric SMILES | CN1C2=C(C(=C(C1=O)F)Nc3ccc(cc3F)I)C(=O)N(C=N2)C[C@H](CO)O |
InChI | InChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1 |
InChIKey | RCLQNICOARASSR-SECBINFHSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 43 |
Chiral Atom Count | 1 |
Bond Count | 45 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB12241 |
---|---|
Name | TAK-733 |
Groups | investigational |
Description | TAK-733 has been used in trials studying the treatment of Advanced Metastatic Melanoma, Advanced Nonhematologic Malignancies, and Advanced Non-hematologic Malignancies. |
Synonyms |
|
Categories |
|
CAS number | 1035555-63-5 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1615025 |
PubChem | 24963252 |
ChEMBL | CHEMBL1615025 |